Corvus Pharmaceuticals, Inc.
CRVS
$13.33
-$0.60-4.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 189.26% | 435.41% | 9.21% | 57.71% | 57.49% |
| Total Receivables | 613.90% | 427.75% | 73.15% | 56.56% | 112.30% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.32% | -79.68% | -63.19% | -42.53% | -33.93% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 347.38% | 254.31% | -47.81% | 3.78% | 102.33% |
| Total Current Assets | 191.59% | 427.46% | 7.00% | 55.97% | 57.03% |
|
|
|||||
| Total Current Assets | 191.59% | 427.46% | 7.00% | 55.97% | 57.03% |
| Net Property, Plant & Equipment | 18.08% | -18.02% | -20.26% | 152.31% | 63.77% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 173.64% | 173.45% | 35.28% | 238.10% | 385.27% |
| Total Assets | 167.46% | 325.98% | 3.21% | 36.83% | 38.57% |
|
|
|||||
| Total Accounts Payable | 29.01% | 259.10% | -3.52% | 5.39% | 158.62% |
| Total Accrued Expenses | 90.10% | 89.62% | 81.84% | 35.20% | 14.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 27.89% | 34.17% | 117.84% | 7.06% | -49.29% |
| Total Finance Division Other Current Liabilities | -13.58% | -94.95% | -99.18% | -98.60% | -95.29% |
| Total Other Current Liabilities | -13.58% | -94.95% | -99.18% | -98.60% | -95.29% |
| Total Current Liabilities | 60.75% | 30.51% | -73.50% | -82.60% | -36.22% |
|
|
|||||
| Total Current Liabilities | 60.75% | 30.51% | -73.50% | -82.60% | -36.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -62.36% | -51.32% | -43.01% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 51.05% | 23.76% | -72.72% | -81.24% | -30.76% |
|
|
|||||
| Common Stock & APIC | 42.31% | 54.44% | 10.10% | 18.78% | 18.61% |
| Retained Earnings | -13.89% | -11.57% | -3.85% | -3.92% | -13.09% |
| Treasury Stock & Other | -12.63% | 10.21% | 30.43% | -43.63% | 15.28% |
| Total Common Equity | 180.86% | 387.95% | 87.93% | 478.35% | 56.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 180.86% | 387.95% | 87.93% | 478.35% | 56.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 180.86% | 387.95% | 87.93% | 478.35% | 56.62% |
|
|
|||||